Piper Sandler on Bristol-Myers Squibb Co. (BMY): 'Milvexian Did Strike Us As High-Risk'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 60.97 -0.58 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.55 | 52 Week High | $77.12 | |||
| Open | $60.50 | 52 Week Low | $49.03 | |||
| Day High | $61.34 | P/E | 39.59 | |||
| Day Low | $60.33 | EPS | $1.54 | |||
| Volume | 681,526 | |||||
